Dr Mark McPhail
Reader in Experimental Medicine
Research interests
- Biomedical and life sciences
Biography
Mark McPhail is a Reader in Experimental Medicine and Honorary Consultant in Liver Intensive Care and Hepatology. He graduated with a PhD in Physics from Strathclyde University and then Medicine and Surgery from Glasgow University. He is interested in immunometabolism in liver failure syndromes and how lipid derangement affects innate immunity. He also has a keen interest in statistical methods and outcome research and is the Chief Scientific Investigator of the BOPPP (Betablockers or Placebo in Portal Hypertension) study. His group is based in the Insitute of Liver Studies at Denmark Hill and he collaborates with Imperial College and the United States Acute Liver Failure Study Group.
Research
Lipids and Membranes Research Interest Group
A Lipids and Membranes Research Interest Group
Immunometabolism (iMet) Research Interest Group (RIG)
The aim of the i-met research interest group is to stimulate novel collaborations in the field of Immunometabolism, a young but rapidly growing field of research.
The Liver Intensive Therapy Unit - Liver Failure Syndromes
King's College Hospital hosts a unique 19-bedded specialist critical care unit, the Liver Intensive Therapy Unit (LITU). For more than 30 years, it has been a leader in research into the pathogenesis of liver failure and associated extra-hepatic organ dysfunction and failure and the optimal application of established and novel therapies.
Centre for Critical Illness Research
CCIR, a cross-faculty centre for academic excellence, focusses on critical illness.CCIR brings together interdisciplinary academics and clinicians to translate early scientific breakthroughs into effective prevention, diagnosis, and treatment strategies for critical illness and to enable healthy critical illness survivorship for children and adults.
News
Quest for biomarkers in blood samples of COVID-19 patients to better understand host response
Researchers from the School of Cardiovascular Medicine & Sciences have been analysing blood samples of patients with a confirmed COVID-19 diagnosis to better...
How technology designed for outer space can help detect disease on planet earth
Researchers are trialing technology used to study gases in space to detect sepsis.
Research
Lipids and Membranes Research Interest Group
A Lipids and Membranes Research Interest Group
Immunometabolism (iMet) Research Interest Group (RIG)
The aim of the i-met research interest group is to stimulate novel collaborations in the field of Immunometabolism, a young but rapidly growing field of research.
The Liver Intensive Therapy Unit - Liver Failure Syndromes
King's College Hospital hosts a unique 19-bedded specialist critical care unit, the Liver Intensive Therapy Unit (LITU). For more than 30 years, it has been a leader in research into the pathogenesis of liver failure and associated extra-hepatic organ dysfunction and failure and the optimal application of established and novel therapies.
Centre for Critical Illness Research
CCIR, a cross-faculty centre for academic excellence, focusses on critical illness.CCIR brings together interdisciplinary academics and clinicians to translate early scientific breakthroughs into effective prevention, diagnosis, and treatment strategies for critical illness and to enable healthy critical illness survivorship for children and adults.
News
Quest for biomarkers in blood samples of COVID-19 patients to better understand host response
Researchers from the School of Cardiovascular Medicine & Sciences have been analysing blood samples of patients with a confirmed COVID-19 diagnosis to better...
How technology designed for outer space can help detect disease on planet earth
Researchers are trialing technology used to study gases in space to detect sepsis.